Mass-cytometric analysis revealed a distinct signature of NKG2D-CAR T cells responding to NKG2D-ligand positive leukemia targets when compared to Empty control T cells or NKG2D-CAR T cells lacking NKG2D-ligand recognition. This evidence concerns the gene KLRK1 and leukemia.